Plain-English translation of NCT07645443 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The FEEL-GOOD trial is testing a new type of group therapy called mindfulness-based group therapy for young adults (ages 16–35) who have recently experienced their first episode of psychosis. The therapy teaches people how to use mindfulness — paying attention to the present moment without judgment — and emotion regulation skills to better cope with distressing symptoms. Participants will receive this new therapy plus their regular treatment, and researchers will measure whether it helps reduce psychotic symptoms and improves emotional well-being.
Early psychosis is a critical time when treatment can make the biggest difference in how people recover. While standard treatments exist, researchers want to know if adding mindfulness and emotion skills training can help young patients manage their symptoms better and feel less distressed by them.
You likely qualify if…
You likely don't qualify if…
If you join, you will be randomly assigned to either receive the mindfulness group therapy plus your regular treatment, or to continue with regular treatment alone. The therapy includes one individual preparation session and eight group sessions held over 4 weeks, with 4–8 other participants in each session. The sessions teach you about emotions, mindfulness techniques, and ways to cope with distressing feelings. You will also be asked to practice skills at home between sessions. You will complete assessments measuring your symptoms and well-being at the start, after 4 weeks, and again at 6 months.
AI-generated summary from trial data · Oct 7, 2026 · Not medical advice
Germany